Literature DB >> 10435565

Stromal tumors of the anorectum: a clinicopathologic study of 22 cases.

J A Tworek1, J R Goldblum, S W Weiss, J K Greenson, H D Appelman.   

Abstract

Stromal tumors of the anorectum are a rare group of mesenchymal tumors that often have a protracted clinical course. We sought to determine which clinical, morphologic, and immunophenotypic features correlated with an adverse outcome in 22 patients with anorectal stromal tumors. An adverse outcome, defined as either tumor recurrence or metastasis, occurred in nine patients. Seven patients had metastases, two of whom also had local recurrences. Four of these patients also died from their disease. One patient had one local recurrence, and one patient had two local recurrences; neither of these patients had metastases. Recurrences were found as long as 103 months and metastases as late as 117 months after initial presentation. However, for patients without an adverse outcome, maximum follow-up was only 84 months. Thus both recurrence and metastasis may not appear until several years after treatment, indicating that a long-term follow-up period, probably longer than available for many tumors without an adverse outcome in this study, is needed before a patient can be considered to be cured. Tumor size greater than five centimeters correlated with an adverse outcome. However, given the protracted course of these tumors and the relatively limited follow-up available, other features such as location within the muscularis propria, mitotic activity, necrosis, and pleomorphism that did not significantly correlate with an adverse outcome may become significant with longer follow-up periods. We also found that on the basis of morphologic appearance and whether tumors were confined to the submucosa or located within the muscularis propria, anorectal stromal tumors could be divided into three groups, and that the behavior of anorectal stromal tumors may also depend upon their phenotype. The largest group of 17 tumors was located within the muscularis propria, mitotically active, and composed of densely cellular spindle-shaped cells. A second group of two tumors was also located within the muscularis propria and was composed of spindle-shaped cells, but lacked dense cellularity and mitotic activity. The third group was composed of three submucosal, polypoid tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10435565     DOI: 10.1097/00000478-199908000-00013

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

1.  Rare anorectal neoplasms: gastrointestinal stromal tumor, carcinoid, and lymphoma.

Authors:  Elizabeth A Peralta
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 2.  Anal canal gastrointestinal stromal tumors: case report and literature review.

Authors:  Nuno Carvalho; Diogo Albergaria; Rui Lebre; João Giria; Vitor Fernandes; Helena Vidal; Maria José Brito
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 3.  Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.

Authors:  Chandu M V de Silva; Robin Reid
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

Review 4.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

5.  Colorectal gastrointestinal stromal tumors: a brief review.

Authors:  Rishindra M Reddy; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2006-05

6.  Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data.

Authors:  Michael F Ochs; Lori Rink; Chi Tarn; Sarah Mburu; Takahiro Taguchi; Burton Eisenberg; Andrew K Godwin
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

7.  Gastrointestinal stromal tumor of the rectum resected by laparoscopic surgery: report of a case.

Authors:  Takatoshi Nakamura; Atsushi Ihara; Hiroyuki Mitomi; Yukihito Kokuba; Takeo Sato; Heita Ozawa; Kazuhiko Hatade; Wataru Onozato; Masahiko Watanabe
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

8.  Clinicopathological features and prognostic factors of rectal gastrointestinal stromal tumors.

Authors:  C C Xiao; S Zhang; M H Wang; L Y Huang; P Wu; Y Xu; X L Zhu; W Q Sheng; C Y Du; Y Q Shi; Z Q Guan; S J Cai; G X Cai
Journal:  J Gastrointest Surg       Date:  2013-01-04       Impact factor: 3.452

9.  Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case.

Authors:  Yuma Ebihara; Shunichi Okushiba; You Kawarada; Shuji Kitashiro; Hiroyuki Katoh; Satoshi Kondo
Journal:  Surg Today       Date:  2008-02-01       Impact factor: 2.549

Review 10.  The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution.

Authors:  Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2003-02-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.